Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Nektar Therapeutics Reports First Quarter 2009 Financial Results
Date:5/6/2009
e accounts receivable 5,365 7,597 Decrease (increase) in inventories (4,073) 1,160 Decrease (increase) in prepaids and other assets 496 2,044 Increase (decrease) in accounts payable (8,095) (2,033) Increase (decrease) in accrued compensation (6,133) (3,932) Increase (decrease) in accrued clinical trial expenses (2,640) 86 Increase (decrease) in accrued expenses to contract manufacturers - (31,994) Increase (decrease) in accrued expenses 3,364 (123) Increase (decrease) in deferred revenue (3,029) (1,200) Increase (decrease) in other liabilities (1,897) (2,761) ------ ------ Net cash used in operating activities (42,394) (64,972) Cash flows from investing activities: Purchases of property and equipment (5,104) (5,281) Purchases of investments (85,298) (156,092) Maturities of investments 104,458 186,758 Transaction costs from Novartis pulmonary asset sale (4,766) - ------ --- Net cash provided by investing activities 9,290 25,385 Cash flows used in financing activities: Proceeds from issuances of common stock 61 371 Payments of loan and capital lease obligations (302) (411) ---- ---- Net cash used in financing activities
'/>"/>
| SOURCE Nektar Therapeutics Copyright©2009 PR Newswire. All rights reserved |
Related biology technology :
1. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
2. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
3. Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting
4. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
5. Nektar Therapeutics President and CEO Howard Robin to Present at 2007 BIO InvestorForum
6. Nektar Therapeutics to Present at 2007 BMO Capital Markets Focus on Healthcare Conference
7. Nektar Therapeutics President and CEO Howard W. Robin to Present At JPMorgan 26th Annual Healthcare Conference
8. Nektar Appoints Hoyoung Huh, M.D., Ph.D., to Serve on the Companys Board of Directors
9. Nektar Announces Restructuring to Complete Its Transition to a Therapeutics Drug Development Organization
10. West Concludes Agreement with Nektar
11. Nektar to Announce Q1 2008 Financial Results on Wednesday, May 7, 2008, After Close of U.S.-Based Financial Markets
Post Your Comments:
(Date:5/17/2013)... recipient,s immune system identifies the transplanted organ as foreign ... T cells, the immune cells that mediate rejection, must ... order to migrate to the transplanted organ. In this ... Fadi Lakkis and colleagues at the University of Pittsburgh ... cells is not required for migration. Instead, these cells ...
(Date:5/17/2013)... - Elsevier, a world-leading provider of scientific, technical and ... of a recent study in Reproductive BioMedicine ... that those with an abnormal chromosomal composition can be ... to blastocysts, thereby classifying the risk of genetic abnormality ... group has undertaken a retrospective study, using their predictive ...
(Date:5/17/2013)... TRIANGLE PARK, N.C., USA (PRWEB) May 17, 2013 ... Green Globes Certified for sustainability , ... and insect pressures , Syngenta ... opening celebration today at the company’s RTP Innovation Center. ... Lab allows company researchers to simulate any agricultural climate ...
(Date:5/17/2013)... Calif. , May 17, 2013 Cellular ... has achieved 50% enrollment of the total projected ... evaluate the safety and preliminary efficacy of the ... therapy for Knee Osteoarthritis (KOA). To date the ... reported. The Phase I open label ...
Breaking Biology Technology:Breakthrough for IVF? 2Breakthrough for IVF? 3Syngenta Opens Unique $72 Million Advanced Crop Lab 2Syngenta Opens Unique $72 Million Advanced Crop Lab 3Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2... China , May 25 /PRNewswire-Asia-FirstCall/ -- Biostar,Pharmaceuticals, Inc. ... a leading over-the-counter Hepatitis B medicine,Xin Aoxing Oleanolic Acid Capsule ("Xin ... that it has,commenced assembly of its production line for its proprietary ... , ...
... , NEW YORK , May 25 Pfizer Animal ... in aquaculture vaccines, R&D and healthcare diagnostic services. The acquisition further expands ... cattle, swine, poultry and, now, fish. , ... (Logo: http://www.newscom.com/cgi-bin/prnh/20100416/PFIZERLOGO ) , ...
... 25 Today Organic Miracle, Inc. CEO Jerry Bakke , ... have developed a natural, non-toxic solution to the Gulf oil spill contamination ... , , , ... 701 (Building a Better World Green) is a super concentrated, high efficiency, ...
Cached Biology Technology:Biostar Pharmaceuticals, Inc. Begins Assembly of New Production Line 2Biostar Pharmaceuticals, Inc. Begins Assembly of New Production Line 3Biostar Pharmaceuticals, Inc. Begins Assembly of New Production Line 4Pfizer Animal Health Expands Global Commitment to a Safe Food Supply with a New Focus on Healthy Fish 2Pfizer Animal Health Expands Global Commitment to a Safe Food Supply with a New Focus on Healthy Fish 3Pfizer Animal Health Expands Global Commitment to a Safe Food Supply with a New Focus on Healthy Fish 4Organic Miracle, Inc.'s Product, BBW G701, is a Natural, Non-Toxic Means of Stopping and Reversing the Catastrophic Contamination Caused by the Gulf Oil Spill 2Biostar Pharmaceuticals, Inc. Begins Assembly of New Production LinePfizer Animal Health Expands Global Commitment to a Safe Food Supply with a New Focus on Healthy FishOrganic Miracle, Inc.'s Product, BBW G701, is a Natural, Non-Toxic Means of Stopping and Reversing the Catastrophic Contamination Caused by the Gulf Oil Spill
(Date:5/16/2013)... that are about 23 million years old give ... gobioid order, one of the most species-rich groups ... by paleontologist Professor Bettina Reichenbacher from the Division ... Earth and Environmental Sciences at Ludwig-Maximilians-Universitaet (LMU) in ... of fish fossils which they assign to the ...
(Date:5/16/2013)... Abwe, a conservationist working in Cameroon and the manager ... just been awarded the prestigious Whitley award. The ... called "The Green Oscars" because it celebrates the extraordinary ... in developing countries. Abwe was selected for the ... preserve Cameroon,s Ebo Forest and its wildlife inhabitants., HRH ...
(Date:5/15/2013)... gout risk, new research reveals that vitamin C, also ... levels to a clinically significant degree in patients with ... with allopurinol, appears to have a weak effect on ... the results published in the American College of Rheumatology ... Gout is an inflammatory arthritis that causes excruciating pain ...
Breaking Biology News(10 mins):Paleontology: The eloquence of the otoliths 2Paleontology: The eloquence of the otoliths 3Cameroon researcher wins prestigious 'Green Oscar' 2Cameroon researcher wins prestigious 'Green Oscar' 3Vitamin C does not lower uric acid levels in gout patients 2... Clinicians, researchers and allied health professionals with ... and management, are invited to convene in Singapore ... Meeting from December 10-13, 2010. The ... lectures by key international experts and thought leaders ...
... 2010) Rare but devastating, eye cancer can strike anyone ... leaves half of all patients partially blind. But a ... the University of Colorado School of Medicine, may change all ... the eye can block up to 55 percent of harmful ...
... broken by Michigan State University biochemists helps explain ... could lead to discoveries related to plant tolerance ... brings together two classic problems in plant biology," ... molecular biology. "One is that plants protect themselves ...
Cached Biology News:Clinical management of osteoporosis to be focus of Singapore meeting 2Researcher finds revolutionary way to treat eye cancer 2Researchers discover novel mechanism protecting plants against freezing 2| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |